Abstract
Female sexual dysfunction is age-related, progressive, and highly prevalent, affecting 30–50% of American women. While there are emotional and relational elements to female sexual function and response, female sexual dysfunction can occur secondary to medical problems and have an organic basis. This paper addresses anatomy and physiology of normal female sexual function as well as the pathophysiology of female sexual dysfunction. Although the female sexual response is inherently difficult to evaluate in the clinical setting, a variety of instruments have been developed for assessing subjective measures of sexual arousal and function. Objective measurements used in conjunction with the subjective assessment help diagnose potential physiologic/organic abnormalities. Therapeutic options for the treatment of female sexual dysfunction, including hormonal, and pharmacological, are also addressed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Laumann E, Paik A, Rosen R . Sexual dysfunction in the United States prevalence and predictors. JAMA 1999; 281: 537–544.
Spector IP, Carey MP . Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990; 19: 389–408.
Sarrel PM . Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. Int J Impot Res 1998; 10 (Suppl 2): S91–S93; discussion S98–S101.
Basson R et al. Report on the international consensus development conference of female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888–893.
Masters EH, Johnson VE . Human Sexual Response. Little Brown & Co.: Boston, 1966.
Kaplan HS . The New Sex Therapy. Bailliere Tindall: London, 1974.
Graziottin A . Libido. In: John S (ed). Yearbook of the Royal College of Obstetricians and Gynaecologists. RCOG Press-Parthenon Publishing Group, 1996, pp 235–243.
Levin RJ . The physiology of sexual function in women. Clin Obstet Gynecol 1981; 7: 213.
Park K et al. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1998; 249: 612–617.
Rosen RC, Phillips NA, Gendrano N . Oral phentolamine and female sexual arousal disorder: A pilot study. J Sex Marital Ther 1999; 25: 137–144.
Hoyle CH et al. Innervation of vasculature and microvasculature of human vagina by NOS and neuropeptide-containing nerves. J Anat 1996; 188: 633–644.
Hsueh WA . Sexual dysfunction with aging and systemic hypertension. Am J Cardiol 1998; 61: 18H–123H.
Traish AM et al. Development of human and rabbit vaginal smooth muscle cell cultures: Effects of vasoactive agents on intracellular levels of cyclic nucleotides. Mol Cell Biol Res Commun 1999; 2: 131–137.
Helm G, Ottesen B, Fahrenkrug J . Vasoactive intestinal polypeptide in the human female reproductive tract: distribution and motor effects. Biol Reprod 1981; 25: 227–234.
Shen WW, Urosevich Z, Clayton DO . Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med 1999; 44: 535–542.
Sherwin BB, Gelfand MM, Brender W . Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical postmenopausal. Psychosom Med 1985; 47: 339–345.
O'Connell HE, Hutson FM, Anderson CR, Plenter RJ . Anatomical relationship between urethra and clitoris. J Urol 1998; 159: 1892.
Davis SR . Androgens and female sexuality. J Gender Specific Med 2000; 3: 36–40.
Tarcan T et al. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J Urol 1999; 161: 940–944.
Sarrell PM . Sexuality and menopause. Obstet and Gynecol 1990; 75: 26s.
Goldstein I, Berman J . Vasculogenic female sexual dysfunction. Int J Impot Res 1998; 10: 84.
Traish AM et al. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides. Mol Cell Biol Res Commun 1999; 2: 131–137.
Sjoberg I . The vagina: morphological, functional and etiological aspects. Acta Obstet Gynecologic Scand 1992; 71: 84.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berman, J. Physiology of female sexual function and dysfunction. Int J Impot Res 17 (Suppl 1), S44–S51 (2005). https://doi.org/10.1038/sj.ijir.3901428
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901428
Keywords
This article is cited by
-
New Solutions for Old Problems: How Reproductive Tissue Engineering Has Been Revolutionizing Reproductive Medicine
Annals of Biomedical Engineering (2023)
-
Effect of Omega-3 fatty acid supplementation on sexual function of pregnant women: a double blind randomized controlled trial
International Journal of Impotence Research (2022)
-
Local Responses to Genital Arousal — Mechanisms of Lubrication
Current Sexual Health Reports (2022)
-
Local Genital Arousal: Mechanisms for Vaginal Lubrication
Current Sexual Health Reports (2021)
-
Declines in Sexual Activity and Function Predict Incident Health Problems in Older Adults: Prospective Findings from the English Longitudinal Study of Ageing
Archives of Sexual Behavior (2020)